Navigation Links
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results

BEIJING, March 25 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it will host a conference call on Monday, March 31, 2008 at 9:00 a.m. ET to review the Company's fourth quarter and year ended December 31, 2007 financial results and provide an update on recent corporate developments.

To access the conference call, please dial 1-877-407-4018 (USA) or 1-201- 689-8471 (international). A replay of the call will be available from 12:00 p.m. ET on March 31, until April 14, 2008 at midnight. To access the replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) and reference the account number 3055 and the access code 279686.

A live audio webcast of the call will also be available from the Investors section on the corporate web site at . A webcast replay can be accessed on the corporate website beginning March 31, 2008 and the replay will remain available for 30 days.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include HealiveTM (hepatitis A), BiliveTM (combined hepatitis A and B) and AnfluTM (influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, Japanese encephalitis and SARS. Additional information about Sinovac is available on its website, . To be added to our distribution list, please email:

For more information, please contact:

Contact Information:

Helen G. Yang

Sinovac Biotech Ltd.

Tel: +86-10-8289-0088 Ext. 871

Fax: +86-10-6296-6910

Email: '/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Announces Adjournment of Annual General Meeting
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Sinovac Closes $9.75 Million Private Placement
4. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
5. Sinovac Requests Extension for Annual Shareholders Meeting
6. Sinovac Announces Postponement of Annual General Meeting
7. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
8. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
9. Osteotech to Present at the Sidoti Conference in New York
10. BioMS Medical to present at BioCentury Conference
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
Post Your Comments:
(Date:10/8/2015)... ... October 08, 2015 , ... ... exclusive license agreement to develop and commercialize intellectual property rights belonging to The ... from February 2009, and affords exclusive worldwide rights to intellectual property based on ...
(Date:10/7/2015)... India , October 8, 2015 /PRNewswire/ ... --> Medical biotechnology accounts for largest ... of bioinformatics in drug discovery and development ... . ... On the basis of applications, the ...
(Date:10/7/2015)... ... October 07, 2015 , ... Neil Riordan, PhD to ... Summit Tomorrow, October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. , Dr. ... cell therapy. , He is the Co-Founder and Chief Science Officer of ...
(Date:10/7/2015)...  ChromaDex Corp. (OTCQX: CDXC), an innovator of ... science-based solutions for dietary supplement, food and beverage, ... announced that the October 1 presentation from ... available for on-demand viewing at ...   --> LINK: ...
Breaking Biology Technology:
... ImQuest Life Sciences today presented important new results ... molecules as antiviral agents at the 13th International ... held last week in Washington D.C. ImQuest,s ... of HBV replication, with two compounds yielding potent ...
... be Released Concurrent with AHA PresentationSAN FRANCISCO, March 31 ... a biotechnology company focused on the development of compounds ... announced that an abstract on the Company,s Phase 2 ... poster presentation at the American Heart Association Arteriosclerosis, Thrombosis ...
... Linked to Anti-Viral Agents -- , ... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... further strengthens the company,s intellectual property leadership in ... of life-threatening diseases. The new patent grants ...
Cached Biology Technology:
(Date:10/5/2015)... -- ) releases the ... NXTD ), a biometric authentication company focused on ... ) releases the following market and company ... biometric authentication company focused on the growing mobile commerce ... ) releases the following market and company ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
(Date:9/28/2015)... , September 28, 2015 ... expected to reach USD 12.03 billion by 2020, growing ... Technological advancements such as Backside Illumination (BSI) technique to ... over the forecast period.      (Logo: ... of the chip to reduce loss and, thus, reduce ...
Breaking Biology News(10 mins):
... German . Toxins from Bacillus thuringiensis ... conventional farming to manage pest insects. Sprayed as pesticides or ... in pest control since 1938, minimize herbivory in crops, such ... producing transgenic crops have been grown, which successfully control pests ...
... at the San Diego Supercomputer Center (SDSC) and ... (Calit2) at the University of California, San Diego, ... from the National Science Foundation (NSF) to create ... will develop new tools to help manage ever-growing ...
... 18, 2011 Acclaimed UC Irvine geneticist Francisco J. Ayala, ... and evolution, will donate $10 million to the School of ... faculty member, will be funded with profits from flourishing vineyards ... things, you should do them," said the University Professor and ...
Cached Biology News:
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... For real-time or pre-programmed liquid ... electrochemistry, or general liquid-handling research ... millisecond accuracy. Run ... Microprocessor-based for accuracy and ...
Biology Products: